Annual report pursuant to Section 13 and 15(d)

Segment Information

v3.21.1
Segment Information
 12 Months Ended
Jan. 02, 2021
Segment Reporting [Abstract]  
Segment Information

Note 21:

  Segment information

We operate within targeted markets through three reportable segments: biotechnology, recycling and technology. The biotechnology segment commenced operations in September 2019 and is focused on development of new and innovative solutions for ending the opioid epidemic ranging from digital technologies to educational advocacy. The recycling segment includes all fees charged and costs incurred for collecting, recycling and installing appliances for utilities and other customers. The recycling segment also includes byproduct revenue, which is primarily generated through the recycling of appliances. The nature of products, services and customers for both segments varies significantly. As such, the segments are managed separately. Our Chief Executive Officer has been identified as the Chief Operating Decision Maker (“CODM”). The CODM evaluates performance and allocates resources based on sales and income from operations of each segment. Operating loss represents revenues less cost of revenues and operating expenses, including certain allocated selling, general and administrative costs. There are no intersegment sales or transfers.

The following tables present our segment information for fiscal years 2020 and 2019:

 

 

 

Fiscal Years Ended

 

 

 

January 2, 2021

 

 

December 28, 2019

 

Revenues

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

33,867

 

 

 

35,097

 

Technology

 

 

—

 

 

 

—

 

Total Revenues

 

$

33,867

 

 

$

35,097

 

Gross profit

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

8,827

 

 

 

7,786

 

Technology

 

 

—

 

 

 

—

 

Total Gross profit

 

$

8,827

 

 

$

7,786

 

Operating loss

 

 

 

 

 

 

 

 

Biotechnology

 

$

(1,738

)

 

$

(1,038

)

Recycling

 

 

(3,172

)

 

 

(6,397

)

Technology

 

 

(4,086

)

 

 

(4,996

)

Total Operating loss

 

$

(8,996

)

 

$

(12,431

)

Depreciation and amortization

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

376

 

 

 

346

 

Technology

 

 

3,746

 

 

 

3,730

 

Total Depreciation and amortization

 

$

4,122

 

 

$

4,076

 

Interest expense, net

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

504

 

 

 

1,480

 

Technology

 

 

—

 

 

 

—

 

Total Interest expense

 

$

504

 

 

$

1,480

 

Net loss before provision for income taxes

 

 

 

 

 

 

 

 

Biotechnology

 

$

(1,738

)

 

$

(1,038

)

Recycling

 

 

(2,980

)

 

 

(9,008

)

Technology

 

 

(4,207

)

 

 

(5,115

)

Total Net loss before provision for income taxes

 

$

(8,925

)

 

$

(15,161

)

 

 

 

As of

 

 

As of

 

 

 

January 2, 2021

 

 

December 28, 2019

 

Assets

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

10,614

 

 

 

11,505

 

Technology

 

 

13,737

 

 

 

17,529

 

Total Assets

 

$

24,351

 

 

$

29,034

 

Intangible Assets

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

470

 

 

 

465

 

Technology

 

 

13,519

 

 

 

17,240

 

Total Intangible Assets

 

$

13,989

 

 

$

17,705